Search Results for: medical

PLoS ONE retracts paper on treatment of tissue disease for lack of ethical approval, erroneous data

PLOS ONE has retracted an article it published earlier this year by a group from Australia who failed to receive adequate ethics approval for their study. The paper, “Late Complications of Clinical Clostridium Histolyticum Collagenase Use in Dupuytren’s Disease,” came from Warren M. Rozen, Yasith Edirisinghe and John Crock (sorry, irony machine not working today). Dupuytren’s causes thickening of the … Continue reading PLoS ONE retracts paper on treatment of tissue disease for lack of ethical approval, erroneous data

Pfizer retracts study of experimental cancer treatment figitumumab for incorrect analyses

Pfizer has retracted a 2009 Journal of Clinical Oncology study purporting to show a benefit of their experimental drug for lung cancer figitumumab after discovering that its clinical lead on the project had done analyses improperly. Here’s the text of the notice:

Tie Retraction Syndrome? Fat chance

Every now and then, we’re accused of “gotcha journalism” here at Retraction Watch. But here’s the story of a paper that we hope you’ll agree is “gotcha” science of the best kind, involving a different kind of retraction. The research is of, shall we say, a pressing problem known as Tie Retraction Syndrome, or TRS … Continue reading Tie Retraction Syndrome? Fat chance

Gastro journal continues tough stance on duplication, with two new retractions

Monica Acalovschi is serious about ridding the literature of duplicate publications. That would seem to be the message of two new retraction notices in the Journal of Gastrointestinal and Liver Diseases, which Acalovschi edits — two retractions that join another for similar reasons, which we covered earlier this year. Here are the notices, from the … Continue reading Gastro journal continues tough stance on duplication, with two new retractions

Most retraction notices don’t involve research misconduct or flawed data: new study

October, apparently, is “studies of retractions month.” First there was a groundbreaking study in PNAS, then an NBER working paper, and yesterday PLoS Medicine alerted us to a paper their sister journal, PLoS ONE, published last week, “A Comprehensive Survey of Retracted Articles from the Scholarly Literature.” The study, by Michael L. Grieneisen and Minghua Zhang, … Continue reading Most retraction notices don’t involve research misconduct or flawed data: new study

Bitter authorship issues prompt Expression of Concern in rheumatology journal

A difficult authorship dispute, involving two journals and at least two continents, has led to an Expression of Concern in the Brazilian Journal of Rheumatology. Here’s the Expression of Concern:

Researchers: Stop the spin and boasting in articles, say other researchers

Researchers often like to complain that science journalists puff up their results to sell newspapers. And there’s no question that reporters make missteps. But a commentary published today in the Archives of Pediatric and Adolescent Medicine brings to mind the old saying about those who live in glass houses not casting the first stones. In … Continue reading Researchers: Stop the spin and boasting in articles, say other researchers

High school whiz kid retracts PLoS ONE herd immunity paper

It’s pretty impressive to publish two peer-reviewed papers on complicated vaccination models while you’re still in high school. So it’s not surprising that Nathan Georgette, who grew up outside of Jacksonville, Florida, earned a prestigious fellowship from the Davidson Institute for Talent Development. But perhaps even more impressive is realizing you’ve made a fundamental error … Continue reading High school whiz kid retracts PLoS ONE herd immunity paper

Final report on cardiology researcher Poldermans confirms claims of misconduct

Erasmus Medical Center in the Netherlands has released the final report on Don Poldermans, finding that the institution’s once-star cardiology researcher committed misconduct. As Larry Husten of CardioBrief reports, Erasmus MC’s investigation included that Poldermans — perhaps best known for his work on beta-blockers — has admitted to acts of misconduct but not to fraud. … Continue reading Final report on cardiology researcher Poldermans confirms claims of misconduct

Another retraction for Anil Potti, with an inscrutable notice

We’ve seen a lot of retraction notices for work by Anil Potti — 10, to be precise, along with 7 corrections and one partial retraction notice. As notices go, they tend to be pretty complete. So when we saw one in CHEST for this 2008 abstract, we were expecting something similar. Instead, we were confused. … Continue reading Another retraction for Anil Potti, with an inscrutable notice